⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Caliway Makes First ECO 2026 Oral Presentation on Preclinical Data of CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies, Attracting Strong Interest from International Experts and Global Pharmaceutical Companies for Its Systemic Metabolic
prnewswire.com
ABBV
AZN
BMY
LLY
NVO
Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion
globenewswire.com
GILD
NVS
BMY
NVO
Etavopivat Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
globenewswire.com
NVO
ESGE-Tage 2026: Endoskopisches Verfahren führt kurzfristig zu größerem Gewichtsverlust als orales Semaglutid, so eine Studie USA - Deutsch USA - Français USA - English USA - español
prnewswire.com
NVO
ESGE Days 2026: el procedimiento endoscópico se asocia con una mayor pérdida de peso que la semaglutida oral USA - español USA - Français USA - English USA - Deutsch
prnewswire.com
NVO
Journées ESGE 2026 : Une étude révèle que la procédure endoscopique est associée à une perte de poids à court terme plus importante que le semaglutide oral USA - Français USA - English USA - Deutsch USA - español
prnewswire.com
NVO
Wegovy® pill delivered 21.6% weight loss in early responders and doubled mobility improvement, according to new Novo Nordisk data at ECO2026
globenewswire.com
NVO
The $59B Quiet Shift Reshaping How Patients Access Care
prnewswire.com
NVO
DNA
HIMS
MNKD
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
globenewswire.com
NVO
PFE
LLY
HIMS
Cellular Intelligence, an AI-native TechBio, Enters Agreement with Novo Nordisk to Advance Clinical-Stage Parkinson's Cell Therapy USA - English Danmark - Dansk Danmark - English
prnewswire.com
NVO
AMD